Contact
Please use this form to send email to PR contact of this press release:
ADMS INVESTOR ALERT: ROSEN, A TOP LAW FIRM, Reminds Adamas Pharmaceuticals, Inc. Investors of Important February 10th Deadline in Securities Class Action – ADMS
TO: